RADX Protects against Intestinal Inflammation by Restraining IFI16-Mediated Innate Immunity

Researchers identified RADX, a structural antagonist to RAD51 and a key regulator of replication fork stability, as a critical suppressor of intestinal inflammation by limiting innate immune sensing of replication-associated DNA damage.